FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2085800014> ?p ?o ?g. }

• W2085800014 endingPage "645" @default.
• W2085800014 startingPage "641" @default.
• W2085800014 abstract "To determine the prevalence of chronic liver disease in adults with homozygous (Pi ZZ) and heterozygous (Pi Z) alpha 1-antitrypsin deficiency and to assess the presence of other possible risk factors for the development of chronic active hepatitis and cirrhosis of the liver in these patients.Cross-sectional study.A referral-based university hospital.Consecutive patients (164) with the Pi ZZ and Pi Z phenotype with and without chronic liver disease.The presence of antibody to hepatitis C virus (anti-HCV) was determined using an assay incorporating synthetic peptide antigen from capsid protein (United Biomedical [UBI] assay) and a second-generation enzyme immunoassay (Abbott test); the presence of antibody to hepatitis B virus (anti-HBV) was determined using radioimmunoassays incorporating hepatitis B surface antigen (HBsAg) and hepatitis B core antigen (HBcAg); assays for antinuclear antibody and antimitochondrial antibody (M2 subtype) were also done, and alcohol abuse was assessed by history.Among patients with cirrhosis (32%), 62% were anti-HCV positive by the Abbott test (P = 0.006), and 41% were anti-HCV positive by the UBI assay (P = 0.007). Thirty-three percent of patients with cirrhosis had hepatitis B virus (HBV) infection (P = 0.01); 41% had a history of alcoholism; and 12% had features of autoimmune liver disease. Only five patients (9%) with cirrhosis had no other risk factor for chronic liver disease. Among patients with chronic active hepatitis (7%), 80% were anti-HCV positive by the Abbott test (P = 0.002), and 75% were anti-HCV positive by the UBI assay (P less than 0.001). Thirty percent of patients with chronic active hepatitis had HBV infection (P = 0.023); 18% had autoimmune hepatitis; and 8% abused alcohol. Only two patients (17%) had no additional risk factor for the development of chronic active hepatitis. Among patients with steatosis of the liver (48%), 5% were anti-HCV positive by the Abbott test, and none were anti-HCV positive by the UBI assay; 18% had serologic evidence of past HBV infection, and 28% abused alcohol. Among patients without chronic liver disease (13%), no viral infection could be found; 9% were alcoholics.Chronic liver disease in patients with alpha 1-antitrypsin deficiency is associated with a high prevalence of viral infection; this infection, rather than alpha 1-antitrypsin deficiency alone, may be the cause of the liver disease in such patients." @default.
• W2085800014 created "2016-06-24" @default.
• W2085800014 creator A5006150127 @default.
• W2085800014 creator A5021321712 @default.
• W2085800014 creator A5041718629 @default.
• W2085800014 creator A5050589523 @default.
• W2085800014 creator A5070925632 @default.
• W2085800014 creator A5071232329 @default.
• W2085800014 date "1992-10-15" @default.
• W2085800014 modified "2023-10-16" @default.
• W2085800014 title "High Prevalence of Viral Infection in Adults with Homozygous and Heterozygous Alpha_1-Antitrypsin Deficiency and Chronic Liver Disease" @default.
• W2085800014 cites W1486418160 @default.
• W2085800014 cites W1565145764 @default.
• W2085800014 cites W1962242957 @default.
• W2085800014 cites W1967476376 @default.
• W2085800014 cites W1974312609 @default.
• W2085800014 cites W1979866509 @default.
• W2085800014 cites W1982131103 @default.
• W2085800014 cites W1983373536 @default.
• W2085800014 cites W2005820299 @default.
• W2085800014 cites W2012548620 @default.
• W2085800014 cites W2014753171 @default.
• W2085800014 cites W2018508540 @default.
• W2085800014 cites W2054883279 @default.
• W2085800014 cites W2054920939 @default.
• W2085800014 cites W2076800268 @default.
• W2085800014 cites W2081686005 @default.
• W2085800014 cites W2107111755 @default.
• W2085800014 cites W2107524597 @default.
• W2085800014 cites W2108896634 @default.
• W2085800014 cites W2142395184 @default.
• W2085800014 cites W2145835977 @default.
• W2085800014 cites W2146017614 @default.
• W2085800014 cites W2323886210 @default.
• W2085800014 cites W2325223078 @default.
• W2085800014 cites W2334275983 @default.
• W2085800014 cites W2887570837 @default.
• W2085800014 doi "https://doi.org/10.7326/0003-4819-117-8-641" @default.
• W2085800014 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1530195" @default.
• W2085800014 hasPublicationYear "1992" @default.
• W2085800014 type Work @default.
• W2085800014 sameAs 2085800014 @default.
• W2085800014 citedByCount "100" @default.
• W2085800014 countsByYear W20858000142012 @default.
• W2085800014 countsByYear W20858000142013 @default.
• W2085800014 countsByYear W20858000142014 @default.
• W2085800014 countsByYear W20858000142016 @default.
• W2085800014 countsByYear W20858000142017 @default.
• W2085800014 countsByYear W20858000142018 @default.
• W2085800014 countsByYear W20858000142019 @default.
• W2085800014 countsByYear W20858000142021 @default.
• W2085800014 countsByYear W20858000142022 @default.
• W2085800014 countsByYear W20858000142023 @default.
• W2085800014 crossrefType "journal-article" @default.
• W2085800014 hasAuthorship W2085800014A5006150127 @default.
• W2085800014 hasAuthorship W2085800014A5021321712 @default.
• W2085800014 hasAuthorship W2085800014A5041718629 @default.
• W2085800014 hasAuthorship W2085800014A5050589523 @default.
• W2085800014 hasAuthorship W2085800014A5070925632 @default.
• W2085800014 hasAuthorship W2085800014A5071232329 @default.
• W2085800014 hasConcept C126322002 @default.
• W2085800014 hasConcept C159654299 @default.
• W2085800014 hasConcept C203014093 @default.
• W2085800014 hasConcept C2522874641 @default.
• W2085800014 hasConcept C2776029263 @default.
• W2085800014 hasConcept C2776408679 @default.
• W2085800014 hasConcept C2776455275 @default.
• W2085800014 hasConcept C2777075537 @default.
• W2085800014 hasConcept C2777214474 @default.
• W2085800014 hasConcept C2777382497 @default.
• W2085800014 hasConcept C2777410769 @default.
• W2085800014 hasConcept C2779102576 @default.
• W2085800014 hasConcept C2779729466 @default.
• W2085800014 hasConcept C2780593183 @default.
• W2085800014 hasConcept C71924100 @default.
• W2085800014 hasConcept C90924648 @default.
• W2085800014 hasConceptScore W2085800014C126322002 @default.
• W2085800014 hasConceptScore W2085800014C159654299 @default.
• W2085800014 hasConceptScore W2085800014C203014093 @default.
• W2085800014 hasConceptScore W2085800014C2522874641 @default.
• W2085800014 hasConceptScore W2085800014C2776029263 @default.
• W2085800014 hasConceptScore W2085800014C2776408679 @default.
• W2085800014 hasConceptScore W2085800014C2776455275 @default.
• W2085800014 hasConceptScore W2085800014C2777075537 @default.
• W2085800014 hasConceptScore W2085800014C2777214474 @default.
• W2085800014 hasConceptScore W2085800014C2777382497 @default.
• W2085800014 hasConceptScore W2085800014C2777410769 @default.
• W2085800014 hasConceptScore W2085800014C2779102576 @default.
• W2085800014 hasConceptScore W2085800014C2779729466 @default.
• W2085800014 hasConceptScore W2085800014C2780593183 @default.
• W2085800014 hasConceptScore W2085800014C71924100 @default.
• W2085800014 hasConceptScore W2085800014C90924648 @default.
• W2085800014 hasIssue "8" @default.
• W2085800014 hasLocation W20858000141 @default.
• W2085800014 hasLocation W20858000142 @default.
• W2085800014 hasOpenAccess W2085800014 @default.
• W2085800014 hasPrimaryLocation W20858000141 @default.
• W2085800014 hasRelatedWork W1592743141 @default.

• next